Physician Wealth Advisors’s Krystal Biotech KRYS Stock Holding History

Physician Wealth Advisors’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.86K	Buy	5 +1	+25%	+$299	﹤0.01%	1539
2026 Q1	$1.03K	Buy	4 +2	+100%	+$532	﹤0.01%	1665
2025 Q4	$494	Buy	+2	New	+$421	﹤0.01%	1891

Other funds holding KRYS

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

Confluence Wealth Services Mcmurray, Pennsylvania $3.5B AUM 22.08% 1-Year Est. Return

Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return

Physician Wealth Advisors's KRYS Position: Q2 2026 in Review

Physician Wealth Advisors increased its Krystal Biotech (KRYS) stake by 25% in Q2 2026, buying an estimated $299 and bringing the position to 5 shares worth $1.86K. The position accounts for ﹤0.01% of the portfolio, ranked #1539.

Physician Wealth Advisors first reported a position in KRYS in Q4 2025 and has held it in 3 quarters since. 51 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

Physician Wealth Advisors held 5 shares of Krystal Biotech worth $1.86K as of Q2 2026.
Physician Wealth Advisors bought 1 Krystal Biotech share in Q2 2026, an estimated $299.
Krystal Biotech made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1539 holding.
Physician Wealth Advisors first reported a position in Krystal Biotech in Q4 2025 and has held it in 3 quarters since.
51 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.